Cargando…

First-in-Human Phase 1 Studies in Oncology: The New Challenge for Investigative Sites

Phase 1 first-in-human studies with anti-cancer products differ from other phase 1 studies in that they are evaluated in patients rather than healthy volunteers. The rationale design of targeted drugs triggers changes in the design of these studies. Patient populations are more precisely defined and...

Descripción completa

Detalles Bibliográficos
Autor principal: Salzberg, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rambam Health Care Campus 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678815/
https://www.ncbi.nlm.nih.gov/pubmed/23908831
http://dx.doi.org/10.5041/RMMJ.10074